Dr. Robert Charles Bucelli, MD

Dr. Bucelli practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Bucelli's NPI, 1295932960, was assigned on June 27, 2007. Dr. Bucelli graduated from State University of New York at Buffalo School of Medicine in 2007. Dr. Bucelli holds Missouri license 2011015549.

Dr. Bucelli's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Bucelli also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Bucelli's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Bucelli is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Bucelli to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bucelli practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bucelli's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bucelli is licensed in Missouri.

CMS data shows 435 Medicare services from Dr. Bucelli across 12 procedure codes in 2024, for 187 Medicare patients. Medicare paid $34,297 for them.

CMS counts 187 Medicare patients who saw Dr. Bucelli in 2024. The largest group is 65 to 74, with 90 patients. 70% of them have high blood pressure, and 70% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bucelli's median patient age at 68, with 49% women.

In 2024, Dr. Bucelli wrote 471 Medicare Part D claims for 67 patients. 71% of them were for generic drugs. CMS names the drug for 364 of them, across 15 drugs with 11 or more claims each, at $1,029,661 in total drug cost. In 2023, CMS named 364 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bucelli for performance year 2024, reported as part of a group. Dr. Bucelli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 72 papers to Dr. Bucelli, published from 2012 to 2025. 2019 was the busiest year, with 9. The most frequent topics are Amyotrophic Lateral Sclerosis, Superoxide Dismutase-1 and Autoantibodies. Dr. Bucelli has published most often in Muscle Nerve. Dr. Bucelli's most frequent co-authors are Gregory Scott Day, MD, Alan Pestronk, MD and Jonathan D. Glass, MD.

Dmand AI links Dr. Bucelli to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Amyotrophic Lateral Sclerosis and TDP-43 Proteinopathies.

CMS Open Payments shows 29 general payments to Dr. Bucelli from 5 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 89% of the total. Biogen, Inc. paid the most, $14,849. It also lists 14 research payments totaling $14,093 from 2018 to 2024.

Dr. Bucelli graduated from State University of New York at Buffalo School of Medicine in 2007.